Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OVID compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
OVID
Ovid Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
OVID
Ovid Therapeutics Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
OVID, solid
LLY, dashed
OVID
Ovid Therapeutics Inc.
Change
2.86
▲
+10.68%
· post 2.90
Mkt cap
$503.9M
Revenue
$733,000
Q2 FY26
Revenue
$7M
FY25
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
OVID
Ovid Therapeutics Inc.
vs
LLY
ELI Lilly & Co
2.86
▲
+10.68%
post 2.90
Price
1,360.90
▼
−0.28%
post 1,358.90
$503.9M
Mkt cap
$1.2T
Q2 FY26
$733,000
Revenue
$24.4B
Q3 FY26
FY25
$7M
Revenue
$65.2B
FY25
Change
Change
OVID
2.86
▲
+10.68%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26